GC
CL icon

Grimes & Company’s Colgate-Palmolive CL Stock Holding History

Grimes & Company’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
12,509
-142
-1% -$12.4K 0.02% 243
2026
Q1 		$1.08M Buy
12,651
+157
+1% +$14K 0.03% 232
2025
Q4 		$987K Sell
12,494
-27
-0.2% -$2.12K 0.02% 248
2025
Q3 		$1M Buy
12,521
+26
+0.2% +$2.22K 0.02% 234
2025
Q2 		$1.14M Buy
12,495
+118
+1% +$10.8K 0.03% 204
2025
Q1 		$1.16M Sell
12,377
-126
-1% -$11.3K 0.04% 178
2024
Q4 		$1.14M Buy
12,503
+410
+3% +$39.1K 0.03% 189
2024
Q3 		$1.26M Sell
12,093
-94
-0.8% -$9.58K 0.03% 171
2024
Q2 		$1.18M Sell
12,187
-7
-0.1% -$646 0.04% 164
2024
Q1 		$1.1M Buy
12,194
+23
+0.2% +$1.95K 0.03% 173
2023
Q4 		$970K Buy
12,171
+26
+0.2% +$1.96K 0.03% 173
2023
Q3 		$864K Buy
12,145
+32
+0.3% +$2.39K 0.03% 166
2023
Q2 		$933K Sell
12,113
-1
-0% -$77 0.03% 164
2023
Q1 		$910K Sell
12,114
-5
-0% -$372 0.04% 161
2022
Q4 		$955K Sell
12,119
-1,804
-13% -$135K 0.04% 160
2022
Q3 		$978K Buy
13,923
+1,102
+9% +$86.4K 0.05% 143
2022
Q2 		$1.03M Hold
12,821
– – 0.05% 145
2022
Q1 		$972K Sell
12,821
-277
-2% -$21.9K 0.05% 159
2021
Q4 		$1.12M Buy
13,098
+135
+1% +$10.5K 0.05% 153
2021
Q3 		$980K Sell
12,963
-257
-2% -$20.4K 0.04% 155
2021
Q2 		$1.07M Buy
13,220
+257
+2% +$21K 0.05% 147
2021
Q1 		$1.02M Buy
12,963
+6
+0% +$470 0.05% 144
2020
Q4 		$1.11M Hold
12,957
– – 0.06% 131
2020
Q3 		$1M Buy
12,957
+275
+2% +$21K 0.06% 129
2020
Q2 		$929K Hold
12,682
– – 0.06% 129
2020
Q1 		$842K Hold
12,682
– – 0.08% 124
2019
Q4 		$873K Buy
12,682
+1,300
+11% +$88.6K 0.06% 142
2019
Q3 		$837K Hold
11,382
– – 0.06% 137
2019
Q2 		$816K Hold
11,382
– – 0.06% 131
2019
Q1 		$780K Sell
11,382
-396
-3% -$25.6K 0.06% 127
2018
Q4 		$701K Hold
11,778
– – 0.07% 126
2018
Q3 		$789K Hold
11,778
– – 0.06% 130
2018
Q2 		$763K Sell
11,778
-55
-0.5% -$3.6K 0.07% 131
2018
Q1 		$848K Buy
11,833
+3,722
+46% +$268K 0.08% 125
2017
Q4 		$612K Hold
8,111
– – 0.06% 132
2017
Q3 		$591K Sell
8,111
-1,600
-16% -$115K 0.06% 123
2017
Q2 		$720K Hold
9,711
– – 0.08% 118
2017
Q1 		$711K Hold
9,711
– – 0.08% 118
2016
Q4 		$635K Hold
9,711
– – 0.07% 122
2016
Q3 		$720K Hold
9,711
– – 0.1% 115
2016
Q2 		$711K Hold
9,711
– – 0.1% 112
2016
Q1 		$686K Sell
9,711
-2,524
-21% -$168K 0.09% 110
2015
Q4 		$815K Buy
12,235
+473
+4% +$31.5K 0.11% 105
2015
Q3 		$746K Sell
11,762
-103
-0.9% -$6.73K 0.1% 103
2015
Q2 		$776K Sell
11,865
-60
-0.5% -$4.07K 0.11% 99
2015
Q1 		$827K Buy
11,925
+173
+1% +$12K 0.2% 81
2014
Q4 		$813K Sell
11,752
-186
-2% -$12.6K 0.21% 88
2014
Q3 		$779K Buy
11,938
+30
+0.3% +$1.98K 0.2% 86
2014
Q2 		$812K Sell
11,908
-110
-0.9% -$7.37K 0.21% 87
2014
Q1 		$780K Buy
12,018
+209
+2% +$13.2K 0.22% 83
2013
Q4 		$770K Buy
11,809
+1,625
+16% +$104K 0.23% 79
2013
Q3 		$604K Buy
10,184
+260
+3% +$15.4K 0.2% 83
2013
Q2 		$569K Buy
+9,924
New +$589K 0.21% 83

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Grimes & Company's CL Position: Q2 2026 in Review

Grimes & Company reduced its Colgate-Palmolive (CL) stake by 1.1% in Q2 2026, selling an estimated $12.4K and leaving 12,509 shares worth $1.15M. The position accounts for 0.02% of the portfolio, ranked #243.

Grimes & Company first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.26M in Q3 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Grimes & Company held 12,509 shares of Colgate-Palmolive worth $1.15M as of Q2 2026.
  • Grimes & Company sold 142 Colgate-Palmolive shares in Q2 2026, an estimated $12.4K.
  • Colgate-Palmolive made up 0.02% of Grimes & Company's portfolio in Q2 2026, its #243 holding.
  • Grimes & Company first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Grimes & Company's Colgate-Palmolive position peaked at $1.26M in Q3 2024.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.